Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(521) A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C